aod9604 development discontinued AOD-9604: Lessons from a peptide drug candidate AOD9604

Typically, bacteriostatic water is used, and the volume can range from 1mL to 10mL depending on the specific requirements

Your body is responding to the new signaling, but fat mobilization takes time to produce measurable changes

AOD 9604 is an unlicensed synthetic hGH peptide fragment with limited human trial data, while retatrutide is an investigational triple incretin receptor agonist

AOD 9604 is a synthetic peptide fragment derived from the C-terminus of human growth hormone (HGH)

Manufactured in an FDA Registered Facility using Good Manufacturing Practices (GMPs) *This statement has not been evaluated by the Food and Drug Administration

Always consult with a healthcare provider before starting any new supplement regimen.